Upadacitinib in Behcet's disease - would be very much welcomed, and this open label 8 patient pilot from China is encour
Tweet Content
Upadacitinib in Behcet's disease - would be very much welcomed, and this open label 8 patient pilot from China is encouraging.
We saw similar data for tofacitinib before @ARD_BMJ: https://t.co/YlAQVXpnTY
JAKi (?generic) could be a fantastic option!
#ACR24 ABST2515 @RheumNow https://t.co/65friNLUOK
Links
A pilot study of tofacitinib for refractory Behçet’s syndrome
https://ard.bmj.com/content/79/11/1517
Show on Archive Page
On
Display in Search Results
On
PDQ
Off